Vanguard Group Inc Procept Bio Robotics Corp Transaction History

Vanguard Group Inc

$4.96 Trillion
Q1 2024

A detailed history of Vanguard Group Inc transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Vanguard Group Inc holds 4,246,749 shares of PRCT stock, worth $282 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,246,749

Previous 4,184,585 1.49%

Holding current value

$282 Million

Previous $175 Million 19.67%

% of portfolio

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$40.38 - $50.75 $2.51 Million - $3.15 Million	62,164 Added 1.49%	4,246,749 $210 Million
Q4 2023 Feb 14, 2024	BUY	$24.89 - $43.41 $2.73 Million - $4.76 Million	109,694 Added 2.69%	4,184,585 $175 Million
Q3 2023 Nov 14, 2023	BUY	$30.02 - $38.81 $11.6 Million - $15 Million	385,271 Added 10.44%	4,074,891 $134 Million
Q2 2023 Aug 14, 2023	BUY	$26.7 - $37.02 $11.2 Million - $15.6 Million	420,850 Added 12.87%	3,689,620 $130 Million
Q1 2023 May 15, 2023	BUY	$26.64 - $39.74 $903,255 - $1.35 Million	33,906 Added 1.05%	3,268,770 $92.8 Million

Q4 2022 Feb 10, 2023	BUY	$38.78 - $46.78 $15.4 Million - $18.5 Million	396,340 Added 13.96%	3,234,864 $134 Million
Q3 2022 Nov 14, 2022	BUY	$30.9 - $50.65 $11.8 Million - $19.3 Million	381,894 Added 15.55%	2,838,524 $118 Million
Q2 2022 Aug 12, 2022	BUY	$29.23 - $44.45 $54 Million - $82.2 Million	1,848,617 Added 304.04%	2,456,630 $80.3 Million
Q1 2022 May 13, 2022	BUY	$16.89 - $35.74 $395,884 - $837,709	23,439 Added 4.01%	608,013 $21.3 Million
Q4 2021 Feb 14, 2022	BUY	$24.6 - $46.29 $3.17 Million - $5.96 Million	128,780 Added 28.25%	584,574 $14.6 Million
Q3 2021 Nov 12, 2021	BUY	$35.91 - $41.94 $16.4 Million - $19.1 Million	455,794 New	455,794 $17.4 Million

Others Institutions Holding PRCT

# of Institutions

173

Shares Held

38.1M

Call Options Held

386K

Put Options Held

259K

View Full List

About PROCEPT BioRobotics Corp

Ticker PRCT
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 44,592,300
Market Cap $2.96B
Description
PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...

More about PRCT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Procept Bio Robotics Corp Transaction History